05.17.19
TIME MAGAZINE

Screen+Shot+2019-05-17+at+2.46.33+PM.jpg

How Some Generic Drugs Could Do More Harm Than Good

For the 16 years that Dr. Brian Westerberg, a Canadian surgeon, worked volunteer missions at the Mulago National Referral Hospital in Kampala, Uganda, scarcity was the norm. The patients usually exceeded the 1,500 allotted beds. Running water was once cut off when the debt-ridden hospital was unable to pay its bills.

READ MORE

05.17.19
KIRKUS Book Review

05.16.19
FRESH AIR Interview

BOOK-COVER.jpg

Kirkus gives a starred review to Bottle of Lies

Given the greed of pharmaceutical companies, writes investigative journalist Eban (Dangerous Doses: How Counterfeiters Are Contaminating America's Drug Supply, 2005), cheap generics are essential to money-strapped consumers—and that just may be a death sentence. There are many players and levels in this excellent book, a solid mix of the history of generic drugs, whistleblower tale, and pharmaceutical detective story.

READ MORE

NPR.jpg

The Generic Drugs You're Taking May Not Be As Safe Or Effective As You Think

As the cost of prescription medication soars, consumers are increasingly taking generic drugs: low-cost alternatives to brand-name medicines. Often health insurance plans require patients to switch to generics as a way of controlling costs. But journalist Katherine Eban warns that some of these medications might not be as safe, or effective, as we think.

LISTEN


05.13.19
FOX & FRIENDS

Investigation Into Generic Drug Industry Reveals Rampant Manufacturing Fraud

Author of Bottle of Lies: The Inside Story of the Generic Drug Boom Katherine Eban questions if distant manufacturing plants are being effectively regulated by the FDA.

READ MORE

 

05.13.19
NEW YORK TIMES
Book Review

Screen+Shot+2019-05-13+at+9.50.44+PM.jpg

A New Book Argues That Generic Drugs Are Poisoning Us

Who would ever guess that Gandhi helped start an industry whose corruption now plagues us all? Yet here he is, early in Katherine Eban’s Bottle of Lies, barefoot in his Ahmedabad ashram, urging the chemist Khwaja Abdul Hamied (a fellow Indian nationalist) to copy Western drugs as a way to bring affordable medicine to India’s masses. Thus the generic drug industry began.

READ MORE

05.12.19
NPR
Book Review

gettyimages-477058103-48d5c8225a37206d652251e9d70455c21fe04dcb-s1600-c85.jpg

Bottle Of Lies Exposes The Dark Side Of The Generic Drug Boom 

Generic drugs are supposed to work just as well as their name-brand counterparts.

Once a patent lifts, generic drug companies find alternative ways to manufacture a drug that should work indistinguishably from the name-brand version. In a world of skyrocketing prescription drug prices, cheaper generics have acted as a crucial counterweight.

READ MORE

05.11.19
NEW YORK TIMES
Sunday Review

Delcan & Company

Delcan & Company

Americans Need Generic Drugs. But Can They Trust Them? 

The fake quality-control data, bird infestations and toxic impurities at the overseas plants that could be making your medication. 

READ MORE


05.10.19
CBS THIS MORNING

Bottle of Lies debuts on CBS This Morning

A new book raises questions about whether the federal government is doing enough to ensure the safety of generic drugs coming into the United States. Nine out of every 10 prescriptions filled are for generics. That saves Americans some $3 billion a week over the cost of brand-name drugs.

READ MORE

 

06.08.18
PBS’ THE OPEN MIND

Katherine Eban Appears on PBS’ The Open Mind

On May 18, Katherine Eban appeared on the PBS program, The Open Mind, hosted by Alexander Heffner, to discuss the crisis of quality in generic drug manufacturing, and the dangerous decline in domestic manufacturing.

READ MORE

 

02.04.17

Katherine Eban Awarded McGraw Center Business Reporting Grant

Katherine Eban is one of four veteran journalists who have won grants as recipients of the McGraw Fellowships for Business Journalism. Two of the winning projects will explore challenges facing the modern pharmaceutical industry: Eban's centers on the inadequate regulation of generic drugs produced around the globe.

READ MORE

04.28.15

Katherine Eban Named as One of 32 Inaugural Andrew Carnegie Fellows

The Carnegie Corporation of New York announced the names of 32 Andrew Carnegie Fellows today as the inaugural class of a major annual fellowship program that will provide support for scholars in the social sciences and humanities. The Andrew Carnegie Fellows are an exceptional group of established and emerging scholars, journalists, and authors whose work distills knowledge, enriches our culture, and equips leaders in the realms of science, law, business, public policy and the arts. The fellowships aim to provide new perspectives on the program's overarching theme for 2015: Current and Future challenges to U.S. Democracy and International Order. Winning proposals address issues including policing and race, big data and privacy, the impact of an aging population, the safety of generic drugs, and how attitudes are formed among voters.

Read more about the Carnegie Fellowship in the New York Times

03.20.15

Scott Z. Burns to Adapt Vanity Fair Article on Torture Cheerleaders for HBO

By Mike Hogan

The story of how psychologists helped pioneer the C.I.A.’s post-9/11 program of aggressive interrogation techniques (read: torture), first told by Katherine Eban in Vanity Fair in 2007, is being adapted into a new film by HBO, VF.com can announce.

In the original story, titled “Rorschach and Awe,” Eban described how two psychologists, James Elmer Mitchell and Bruce Jessen, became the C.I.A.’s go-to evangelists for a new menu of abusive techniques, including waterboarding, that they reverse-engineered from an old U.S. program designed to train soldiers to withstand torture by Communist adversaries. Eban’s discoveries were later reinforced by the U.S. Senate’s torture report, released in 2014.

READ MORE


02.25/.15

pharmaevent.jpg

How Indian pharma can clear the U.S. FDA hurdle

On a recent trip to India, Katherine spoke at Gateway House on the challenges facing Indian pharma companies as they face increased FDA scrutiny.

READ MORE